Intrathecal liposomal cytarabine: more friend than foe?

Leuk Lymphoma. 2008 Aug;49(8):1427-30. doi: 10.1080/10428190802220527.
No abstract available

Publication types

  • Comment
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antimetabolites, Antineoplastic
  • Cytarabine / administration & dosage*
  • Cytarabine / toxicity
  • Drug Carriers
  • Humans
  • Injections, Spinal
  • Leukemia / drug therapy
  • Liposomes*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Drug Carriers
  • Liposomes
  • Cytarabine